NO20003830D0 - Fremgangsmote for behandling av akutt intermittent porfyri (AIP) og andre porfyrilidelser - Google Patents

Fremgangsmote for behandling av akutt intermittent porfyri (AIP) og andre porfyrilidelser

Info

Publication number
NO20003830D0
NO20003830D0 NO20003830A NO20003830A NO20003830D0 NO 20003830 D0 NO20003830 D0 NO 20003830D0 NO 20003830 A NO20003830 A NO 20003830A NO 20003830 A NO20003830 A NO 20003830A NO 20003830 D0 NO20003830 D0 NO 20003830D0
Authority
NO
Norway
Prior art keywords
porphyria
enzyme
aip
treatment
pbgd
Prior art date
Application number
NO20003830A
Other languages
English (en)
Other versions
NO327241B1 (no
NO20003830L (no
Inventor
Jens Fogh
Par Gellerfors
Original Assignee
Hemebiotech A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemebiotech A S filed Critical Hemebiotech A S
Publication of NO20003830D0 publication Critical patent/NO20003830D0/no
Publication of NO20003830L publication Critical patent/NO20003830L/no
Publication of NO327241B1 publication Critical patent/NO327241B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20003830A 1998-01-27 2000-07-26 Anvendelse av en katalysator for fremstilling av en farmasoytisk blanding for behandling av akutt intermittent porfyrin og andre porfyrilidelser. NO327241B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK11298 1998-01-27
DKPA199801748 1998-12-30
PCT/DK1999/000040 WO1999037325A2 (en) 1998-01-27 1999-01-27 Method for treating acute intermittent porphyria (aip) and other porphyric diseases

Publications (3)

Publication Number Publication Date
NO20003830D0 true NO20003830D0 (no) 2000-07-26
NO20003830L NO20003830L (no) 2000-09-27
NO327241B1 NO327241B1 (no) 2009-05-18

Family

ID=26063333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003830A NO327241B1 (no) 1998-01-27 2000-07-26 Anvendelse av en katalysator for fremstilling av en farmasoytisk blanding for behandling av akutt intermittent porfyrin og andre porfyrilidelser.

Country Status (11)

Country Link
EP (1) EP1049487B1 (no)
JP (1) JP2002501032A (no)
AT (1) ATE217799T1 (no)
AU (1) AU750143B2 (no)
CA (1) CA2319096C (no)
DE (1) DE69901536T2 (no)
DK (1) DK1049487T3 (no)
ES (1) ES2177240T3 (no)
NO (1) NO327241B1 (no)
PT (1) PT1049487E (no)
WO (1) WO1999037325A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537777B1 (en) 1998-07-27 2003-03-25 Hemebiotech A/S Human porphobilinogen deaminase sequences
JP2003505057A (ja) * 1999-07-27 2003-02-12 ヘム−バイオテック エイ／エス ｒｈＰＢＧＤの製造及び急性間欠性ポルフィリン症（ＡＩＰ）及び他のポルフィリン症の患者を処置するための新規な治療方法
JP4586027B2 (ja) 2004-01-30 2010-11-24 シャイア ファーマシューティカルズ アイルランド リミテッド 組換えアリールスルファターゼａの製造及び精製
MX2008012748A (es) 2006-04-04 2009-01-07 Shire Pharmaceuticals Ireland Un proceso para la concentracion de un polipeptido.
AU2009297243B2 (en) 2008-09-29 2015-10-29 Proyecto De Biomedicina Cima S.L. Porphobilinogen deaminase gene therapy
EP2729566B1 (en) 2011-07-08 2017-03-15 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
SG11201404741VA (en) 2012-02-07 2014-09-26 Global Bio Therapeutics Usa Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
EP2943568B1 (en) 2013-01-09 2019-11-20 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
CN105813579B (zh) 2013-08-08 2019-05-07 全球生物疗法有限公司 用于微创手术过程的夹具装置和其应用
AU2017266948B2 (en) * 2016-05-18 2024-07-04 Fundacion Para La Investigacion Medica Aplicada Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
MA45032A (fr) 2016-05-18 2019-03-27 Fundacion Para La Investig Medica Aplicada Polynucléotides codant pour la porphobilinogène désaminase destinés au traitement de la porphyrie intermittente aiguë
EP3621637A1 (en) * 2017-05-09 2020-03-18 Fundacion para la Investigacion Medica Aplicada Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2657345B2 (ja) * 1992-04-17 1997-09-24 新日本製鐵株式会社 医療用診断装置および疾患判断方法

Also Published As

Publication number Publication date
NO327241B1 (no) 2009-05-18
AU2609799A (en) 1999-08-09
ES2177240T3 (es) 2002-12-01
CA2319096C (en) 2007-07-03
NO20003830L (no) 2000-09-27
PT1049487E (pt) 2002-10-31
AU750143B2 (en) 2002-07-11
DE69901536D1 (de) 2002-06-27
WO1999037325A2 (en) 1999-07-29
ATE217799T1 (de) 2002-06-15
DE69901536T2 (de) 2003-01-16
DK1049487T3 (da) 2002-09-16
CA2319096A1 (en) 1999-07-29
EP1049487A2 (en) 2000-11-08
JP2002501032A (ja) 2002-01-15
EP1049487B1 (en) 2002-05-22
WO1999037325A3 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
NO20003830L (no) Fremgangsmote for behandling av akutt intermittent porfyri (AIP) og andre porfyrilidelser
Distasio et al. Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes.
BR0307871A (pt) Proteìnas contendo domìnio de folistatina
WO2003072715A8 (en) Gasp1: a follistatin domain containing protein
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
WO2003089456A3 (en) Peptide inhibitors of protein kinase c
DE60030970D1 (de) Verfahren und zusammensetzungen für nichtvirale gentherapie zur behandlung von hyperproliferativen krankheiten
ATE326239T1 (de) Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
BR9710686A (pt) Método de tratamento de tumores malignos com tiroxinas análogas não possuindo atividade hormonal siginificativa.
EA200501413A1 (ru) Местные композиции, содержащие l-карнитин
Schallreuter et al. In VivoEvidence for Compromised Phenylalanine Metabolism in Vitiligo
WO2006050211A3 (en) Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
BR112019020367A2 (pt) modulação da expressão do gene para sirtuína com decapeptídeo-12 em progenitores de queratinócito epidérmico
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
Kusakabe et al. Occurrence of a novel enzyme, L-lysine oxidase with antitumor activity in culture extract of Trichoderma viride
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
ATE315084T1 (de) Herstellung von rhpbgd
Krishnaswamy et al. Activated glutamate intermediate in the enzymatic synthesis of glutamine
CN103146789A (zh) 一种胶原蛋白的制备方法
PT1315519E (pt) Composições farmacêuticas e métodos úteis para tratamento de cancro e fibrose hepática
Abe et al. Some properties of a cysteine proteinase inhibitor from corn endosperm
Borsook Enzymatic syntheses of peptide bonds
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
JP2024167913A (ja) 老化の進行抑制剤、およびこれを含む飲食品
WO2023147584A3 (en) Compositions and methods for treating sialidosis

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

MK1K Patent expired